Search Press releases Keywords From To 7 Jun 2016 UCB commitment to addressing real world patient needs on display at the Annual European Congress of Rheumatology (EULAR 2016) Read More 30 May 2016 BRIVIACT® now available in U.S. pharmacies for epilepsy patients living with partial-onset seizures Read More 29 May 2016 Positive VIMPAT® (lacosamide) monotherapy Phase III trial results presented at European Academy of Neurology Congress Read More 28 Apr 2016 UCB's shareholder meeting today Read More 25 Apr 2016 UCB First Three Months Interim Report 2016: Read More 1 Apr 2016 Amgen and UCB present positive data at ENDO 2016 comparing romosozumab with teriparatide Read More Pagination First page Previous page Previous … Page 90 Page 91 Page 92 Page 93 Current page 94 Page 95 Page 96 Page 97 Page 98 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
